Amir Weiss's most recent trade in Teva- Pharmaceutical Industries Ltd. - ADR was a trade of 6,945 Ordinary Shares done at an average price of $37.6 . Disclosure was reported to the exchange on Aug. 21, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Teva- pharma Ind Ltd (ADR) | Mr. Amir Weiss | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 37.61 per share. | 21 Aug 2026 | 6,945 | 13,071 (0%) | 0% | 37.6 | 261,224 | Ordinary Shares |
| Teva- pharma Ind Ltd (ADR) | Mr. Amir Weiss | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.61 per share. | 21 Aug 2026 | 2,500 | 15,571 (0%) | 0% | 19.6 | 49,025 | Ordinary Shares |
| Teva- pharma Ind Ltd (ADR) | Mr. Amir Weiss | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 37.63 per share. | 21 Aug 2026 | 2,500 | 13,071 (0%) | 0% | 37.6 | 94,077 | Ordinary Shares |
| Teva- pharma Ind Ltd (ADR) | Mr. Amir Weiss | Chief Accounting Officer | 21 Aug 2026 | 2,500 | 7,502 | - | - | Stock Options (right to buy) | ||
| Teva- pharma Ind Ltd (ADR) | Mr. Amir Weiss | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 36.00 per share. | 06 May 2026 | 10,679 | 20,016 (0%) | 0% | 36 | 384,444 | Ordinary Shares |
| Teva- pharma Ind Ltd (ADR) | Mr. Amir Weiss | Chief Accounting Officer | 05 Mar 2026 | 3,537 | 10,613 | - | - | Restricted Share Units | ||
| Teva- pharma Ind Ltd (ADR) | Mr. Amir Weiss | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2026 | 3,537 | 30,695 (0%) | 0% | - | Ordinary Shares | |
| Teva- pharma Ind Ltd (ADR) | Mr. Amir Weiss | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2026 | 3,537 | 30,695 (0%) | 0% | - | - | |
| Teva- pharma Ind Ltd (ADR) | Mr. Amir Weiss | Chief Accounting Officer | 04 Mar 2026 | 11,280 | 11,280 | - | - | Restricted Share Units | ||
| Teva- pharma Ind Ltd (ADR) | Mr. Amir Weiss | Chief Accounting Officer | 04 Mar 2026 | 10,679 | 0 | - | - | Restricted Share Units | ||
| Teva- pharma Ind Ltd (ADR) | Mr. Amir Weiss | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2026 | 10,679 | 21,508 (0%) | 0% | - | Ordinary Shares | |
| Teva- pharma Ind Ltd (ADR) | Mr. Amir Weiss | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2026 | 10,679 | 21,508 (0%) | 0% | - | - | |
| Teva- pharma Ind Ltd (ADR) | Mr. Amir Weiss | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2026 | 5,650 | 27,158 (0%) | 0% | - | Ordinary Shares | |
| Teva- pharma Ind Ltd (ADR) | Mr. Amir Weiss | Chief Accounting Officer | 04 Mar 2026 | 5,650 | 11,300 | - | - | Restricted Share Units | ||
| Teva- pharma Ind Ltd (ADR) | Mr. Amir Weiss | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2026 | 5,650 | 27,158 (0%) | 0% | - | - | |
| Teva- pharma Ind Ltd (ADR) | Mr. Amir Weiss | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2026 | 5,179 | 10,829 (0%) | 0% | - | Ordinary Shares | |
| Teva- pharma Ind Ltd (ADR) | Mr. Amir Weiss | Chief Accounting Officer | 03 Mar 2026 | 5,179 | 5,180 | - | - | Restricted Share Units | ||
| Teva- pharma Ind Ltd (ADR) | Mr. Amir Weiss | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2026 | 5,179 | 10,829 (0%) | 0% | - | - | |
| Teva- pharma Ind Ltd (ADR) | Mr. Amir Weiss | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 30.20 per share. | 16 Dec 2025 | 12,300 | 5,650 (0%) | 0% | 30.2 | 371,504 | Ordinary Shares |
| Teva- pharma Ind Ltd (ADR) | Mr. Amir Weiss | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 24.44 per share. | 06 Nov 2025 | 12,300 | 17,950 (0%) | 0% | 24.4 | 300,564 | Ordinary Shares |
| Teva- pharma Ind Ltd (ADR) | Mr. Amir Weiss | Chief Accounting Officer | 05 Mar 2025 | 14,150 | 14,150 | - | - | Restricted Share Units | ||
| Teva- pharma Ind Ltd (ADR) | Mr. Amir Weiss | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2025 | 3,566 | 30,250 (0%) | 0% | - | Ordinary Shares | |
| Teva- pharma Ind Ltd (ADR) | Mr. Amir Weiss | Chief Accounting Officer | 05 Mar 2025 | 3,566 | 0 | - | - | Restricted Share Units | ||
| Teva- pharma Ind Ltd (ADR) | Mr. Amir Weiss | Chief Accounting Officer | 04 Mar 2025 | 10,676 | 10,679 | - | - | Restricted Share Units | ||
| Teva- pharma Ind Ltd (ADR) | Mr. Amir Weiss | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 10,676 | 21,034 (0%) | 0% | - | Ordinary Shares | |
| Teva- pharma Ind Ltd (ADR) | Mr. Amir Weiss | Chief Accounting Officer | 04 Mar 2025 | 5,650 | 16,950 | - | - | Restricted Share Units | ||
| Teva- pharma Ind Ltd (ADR) | Mr. Amir Weiss | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 5,650 | 26,684 (0%) | 0% | - | Ordinary Shares | |
| Teva- pharma Ind Ltd (ADR) | Mr. Amir Weiss | Chief Accounting Officer | 03 Mar 2025 | 5,179 | 10,359 | - | - | Restricted Share Units | ||
| Teva- pharma Ind Ltd (ADR) | Mr. Amir Weiss | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 5,179 | 10,358 (0%) | 0% | - | Ordinary Shares | |
| Teva- pharma Ind Ltd (ADR) | Mr. Amir Weiss | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 16.80 per share. | 15 May 2024 | 15,500 | 17,814 (0%) | 0% | 16.8 | 260,417 | Ordinary Shares |
| Teva- pharma Ind Ltd (ADR) | Mr. Amir Weiss | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 16.65 per share. | 15 May 2024 | 12,635 | 5,179 (0%) | 0% | 16.7 | 210,377 | Ordinary Shares |
| Teva- pharma Ind Ltd (ADR) | Mr. Amir Weiss | Chief Accounting Officer | 05 Mar 2024 | 3,564 | 3,566 | - | - | Restricted Share Units | ||
| Teva- pharma Ind Ltd (ADR) | Mr. Amir Weiss | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2024 | 3,564 | 33,314 (0%) | 0% | - | Ordinary Shares | |
| Teva- pharma Ind Ltd (ADR) | Mr. Amir Weiss | Chief Accounting Officer | 03 Mar 2024 | 22,600 | 22,600 | - | - | Restricted Share Units | ||
| Teva- pharma Ind Ltd (ADR) | Mr. Amir Weiss | Chief Accounting Officer | 03 Mar 2024 | 10,676 | 21,355 | - | - | Restricted Share Units | ||
| Teva- pharma Ind Ltd (ADR) | Mr. Amir Weiss | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2024 | 10,676 | 29,750 (0%) | 0% | - | Ordinary Shares | |
| Teva- pharma Ind Ltd (ADR) | Mr. Amir Weiss | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2024 | 5,179 | 19,074 (0%) | 0% | - | Ordinary Shares | |
| Teva- pharma Ind Ltd (ADR) | Mr. Amir Weiss | Chief Accounting Officer | 03 Mar 2024 | 5,179 | 15,538 | - | - | Restricted Share Units | ||
| Teva- pharma Ind Ltd (ADR) | Mr. Amir Weiss | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 3,219 | 13,895 (0%) | 0% | - | Ordinary Shares | |
| Teva- pharma Ind Ltd (ADR) | Mr. Amir Weiss | Chief Accounting Officer | 28 Feb 2024 | 3,219 | 0 | - | - | Restricted Share Units | ||
| Teva- pharma Ind Ltd (ADR) | Mr. Amir Weiss | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 12.37 per share. | 01 Feb 2024 | 31,766 | 10,676 (0%) | 0% | 12.4 | 392,955 | Ordinary Shares |
| Teva- pharma Ind Ltd (ADR) | Mr. Amir Weiss | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 9.92 per share. | 04 Aug 2023 | 1,981 | 42,442 (0%) | 0% | 9.9 | 19,658 | - |
| Teva- pharma Ind Ltd (ADR) | Mr. Amir Weiss | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2023 | 10,676 | 37,640 (0%) | 0% | - | - | |
| Teva- pharma Ind Ltd (ADR) | Mr. Amir Weiss | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2023 | 3,564 | 41,204 (0%) | 0% | - | - | |
| Teva- pharma Ind Ltd (ADR) | Mr. Amir Weiss | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2023 | 2,406 | 26,964 (0%) | 0% | - | - | |
| Teva- pharma Ind Ltd (ADR) | Mr. Amir Weiss | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 3,219 | 27,777 (0%) | 0% | - | - | |
| Teva- pharma Ind Ltd (ADR) | Mr. Amir Weiss | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2022 | 3,564 | 24,558 (0%) | 0% | - | - | |
| Teva- pharma Ind Ltd (ADR) | Mr. Amir Weiss | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2022 | 2,403 | 20,994 (0%) | 0% | - | - | |
| Teva- pharma Ind Ltd (ADR) | Mr. Amir Weiss | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2022 | 3,219 | 17,610 (0%) | 0% | - | - | |
| Teva- pharma Ind Ltd (ADR) | Mr. Amir Weiss | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2022 | 981 | 18,591 (0%) | 0% | - | - |